The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Consensus statement on the diagnosis, treatment and follow‐up of patients with primary adrenal insufficiency
Open accessAbstract
Primary adrenal insufficiency ( PAI ), or Addison's disease, is a rare, potentially deadly, but treatable disease. Most cases of PAI are caused by autoimmune destruction of the adrenal cortex. Consequently, patients with PAI are at higher risk of developing other autoimmune diseases. The diagnosis of PAI is often delayed by many months, and most patients present with symptoms of acute adrenal insufficiency. Because PAI is rare, even medical specialists in this therapeutic area rarely manage more than a few patients. Currently, the procedures for diagnosis, treatment and follow‐up of this rare disease vary greatly within Europe. The common autoimmune form of PAI is characterized by the presence of 21‐hydroxylase autoantibodies; other causes should be sought if no autoantibodies are detected. Acute adrenal crisis is a life‐threatening condition that requires immediate treatment. Standard replacement therapy consists of multiple daily doses of hydrocortisone or cortisone acetate combined with fludrocortisone. Annual follow‐up by an endocrinologist is recommended with the focus on optimization of replacement therapy and detection of new autoimmune diseases. Patient education to enable self‐adjustment of dosages of replacement therapy and crisis prevention is particularly important in this disease. The authors of this document have collaborated within an EU project (Euadrenal) to study the pathogenesis, describe the natural course and improve the treatment for Addison's disease. Based on a synthesis of this research, the available literature, and the views and experiences of the consortium's investigators and key experts, we now attempt to provide a European Expert Consensus Statement for diagnosis, treatment and follow‐up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“If these diagnoses are excluded, a CT scan of the adrenals may reveal evidence of adrenal infiltrative processes or metastases.”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [181]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common causes of PAI are autoimmune destruction of the adrenal cortex in adults and CAH in children.”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [181]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These etiologies can be screened for using 21-hydroxylase antibodies and a baseline serum 17hydroxyprogesterone level.”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [181]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A daily glucocorticoid dose equivalent to prednisolone ≥ 5 mg, for longer than 1 month represents an adrenal suppressive dosein a proportion of adults [3, 4].”
From Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency (2020) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Therapeutic patient education is recommended by two international consensus statements on the management of PAI.18,64”
From Adrenal crisis: prevention and management in adult patients (2019) · cites this paper as [64]
In the citing paper
“the standard dose (250 μg) corticotropin (1–24 ACTH) test (SDCT) represents the gold standard dynamic test for PAI, while the insulin tolerance test (ITT) is the gold standard if SAI is suspected [1–5].”
In the citing paper
“Although morning serum cortisol concentrations are helpful to determine hypothalamic-pituitary-adrenal axis function, the evidence in the literature is as yet insufficient to support the use of basal cortisol concentrations alone in order to either rule out or confirm AI [1–5].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahonen, P., Myllärniemi, S., Sipilä, I., & Perheentupa, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222601 · Cited by 1,068
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758
Self-citationAutoimmune Polyendocrine Syndromes
Eisenbarth, G. S., & Gottlieb, P. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030158 · Cited by 669
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Self-citationAutoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
Perheentupa, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2611 · Cited by 607
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
Autoimmune Polyglandular Syndromes
Neufeld, M., Maclaren, N. K., & Blizzard, R. M. (1980) · Pediatric Annals · doi:10.3928/0090-4481-19800401-07 · Cited by 471
Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
Meager, A., Visvalingam, K., Peterson, P., Möll, K., Murumägi, A., Krohn, K., Eskelin, P., Perheentupa, J., Husebye, E., Kadota, Y., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030289 · Cited by 453
Self-citationErichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422
Self-citation21-hydroxylase, a major autoantigen in idiopathic Addison's disease
Winqvist, O., Karlsson, F. A., & Kämpe, O. (1992) · The Lancet · doi:10.1016/0140-6736(92)91829-w · Cited by 410
Self-citationClinical manifestations and management of patients with autoimmune polyendocrine syndrome type I
Husebye, E. S., Perheentupa, J., Rautemaa‐Richardson, R., & Kämpe, O. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02090.x · Cited by 370
Self-citationSöderbergh, A., Myhre, A. G., Ekwall, O., Gebre‐Medhin, G., Hedstrand, H., Landgren, E., Miettinen, A., Eskelin, P. M., Halonen, M., Tuomilehto, J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030279 · Cited by 237
Self-citationWinqvist, O., Gustafsson, J., Rorsman, F., Karlsson, F. A., & Kämpe, O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116843 · Cited by 201
Self-citationLong-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1134 · Cited by 189
Autoimmune Addison disease: pathophysiology and genetic complexity
Mitchell, A. L., & Pearce, S. H. S. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.245 · Cited by 120
Self-citationReato, G., Morlin, L., Chen, S., Furmaniak, J., Smith, B. R., Masiero, S., Albergoni, M. P., Cervato, S., Zanchetta, R., & Betterle, C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0414 · Cited by 118
Self-citationFalorni, A., Laureti, S., Bellis, A. D., Zanchetta, R., Tiberti, C., Arnaldi, G., Bini, V., Beck‐Peccoz, P., Bizzarro, A., Dotta, F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030954 · Cited by 94
Self-citationOftedal, B. E., Wolff, A. S. B., Bratland, E., Kämpe, O., Perheentupa, J., Myhre, A. G., Meager, A., Purushothaman, R., Ten, S., & Husebye, E. S. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.002 · Cited by 88
Self-citationLebbe, M., & Arlt, W. (2013) · Clinical Endocrinology · doi:10.1111/cen.12097 · Cited by 86
Self-citationRisk of hip fracture in Addison’s disease: a population-based cohort study
Björnsdottir, S., Sääf, M., Bensing, S., Kämpe, O., Michaëlsson, K., & Ludvigsson, J. F. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02352.x · Cited by 82
Self-citationBjörnsdottir, S., Sundström, A., Ludvigsson, J. F., Blomqvist, P., Kämpe, O., & Bensing, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3561 · Cited by 70
Self-citationAdrenal autoantibodies and organ‐specific autoimmunity in patients with Addison's disease
Söderbergh, A., Winqvist, O., Norheim, I., Rorsman, F., Husebye, E. S., Dolva, Ø., Karlsson, F. A., & Kämpe, O. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8040813.x · Cited by 66
Self-citationRisk of Primary Adrenal Insufficiency in Patients with Celiac Disease
Elfström, P., Montgomery, S., Kämpe, O., Ekbom, A., & Ludvigsson, J. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0960 · Cited by 60
Self-citationHangaard, J., Andersen, M., Grodum, E., Koldkjær, O. G., & Hagen, C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675567 · Cited by 57
Ekman, B., Bachrach‐Lindström, M., Lindström, T., Wahlberg, J., Blomgren, J., & Arnqvist, H. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04352.x · Cited by 54
High Frequency of Coeliac Disease among Patients with Autoimmune Adrenocortical Failure
Myhre, A. G., Aarsetøy, H., Undlien, D. E., Hovdenak, N., Aksnes, L., & Husebye, E. S. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310002544 · Cited by 52
Self-citationGrapefruit juice and licorice increase cortisol availability in patients with Addison's disease
Methlie, P., Husebye, E. E. S., Hustad, S., Lien, E. A., & Løvås, K. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0518 · Cited by 50
Self-citationMHC2TA Single Nucleotide Polymorphism and Genetic Risk for Autoimmune Adrenal Insufficiency
Ghaderi, M., Gambelunghe, G., Tortoioli, C., Brozzetti, A., Jatta, K., Gharizadeh, B., Bellis, A. D., Giraldi, F. P., Terzolo, M., Betterle, C., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0855 · Cited by 48
Self-citationScreening for associated autoimmune disorders in Polish patients with Addison’s disease
Fichna, M., Fichna, P., Gryczyńska, M., Walkowiak, J., Żurawek, M., & Sowiński, J. (2010) · Endocrine · doi:10.1007/s12020-010-9312-x · Cited by 47
Ahlgren, K. M., Moretti, S., Ardesjö-Lundgren, B., Karlsson, I., Åhlin, E., Norling, A., Hallgren, Å., Perheentupa, J., Gustafsson, J., Rorsman, F., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200939883 · Cited by 44
Self-citationClinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure
Sanaker, P. S., Husebye, E. S., Fondenes, O., & Bindoff, L. A. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00850.x · Cited by 36
Self-citationBarbetta, L., Dall’Asta, C., Re, T., Libè, R., Costa, E., & Ambrosi, B. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347262 · Cited by 30
Skinningsrud, B., Husebye, E. S., Gilfillan, G. D., Frengen, E., Erichsen, A., Gervin, K., Ormerod, E., Egeland, T., & Undlien, D. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0923 · Cited by 23
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1210/jc.81.7.2502 · DOI
Cited by
Sorted by citations
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
“2014;275:104–115 (181), with permission.”
Self-citationCongenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationThe Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
Oster, H., Challet, E., Ott, V., Arvat, E., de Kloet, E. R., Dijk, D.-J., Lightman, S., Vgontzas, A., & Van Cauter, E. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1080 · Cited by 548
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467
Self-citationBriet, C., Salenave, S., Bonneville, J., Laws, E. R., & Chanson, P. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1042 · Cited by 418
Metadata
- Authors
- Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., Kämpe, O., Løvås, K., Meyer, G., & Pearce, S. H.
- Affiliations
- Haukeland University Hospital (NO)
- Universitätsklinikum Würzburg (DE)
- University of Birmingham (GB)
- Goethe University Frankfurt (DE)
- Karolinska Institutet (SE)
- University of Padua (IT)
- University of Perugia (IT)
- Newcastle University (GB)
- Department of Endocrinology Medical Center of Postgraduate Education Warsaw Poland
- Uppsala University (SE)
- Corresponding author
- Husebye, E. S.
- ORCID
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2013-12-16
- Volume
- 275
- Issue
- 2
- Pages
- 104-115
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2123534035
- Semantic Scholar
- 2601afd1dd34510db2d279e5db17be74242fad23
- Cited by
- 403
- References
- 34
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 32 · 2023: 24 · 2022: 26 · 2021: 30 · 2020: 43 · 2019: 27 · 2018: 31 · 2017: 40 · 2016: 35 · 2015: 40 · 2014: 28 · 2013: 1
- FWCI
- 27.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- FP7 (201167)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- Addison's disease, autoimmune adrenal insufficiency, 21-hydroxylase autoantibodies, adrenal crisis, hydrocortisone replacement, fludrocortisone, autoimmune disease comorbidity, diagnosis, follow-up, patient education
- MeSH terms
- Acute Disease, Addison Disease, Adrenal Cortex, Adrenal Insufficiency, Algorithms, Autoantibodies, Chronic Disease, Cortisone, Diagnosis, Differential, Drug Administration Schedule, Drug Interactions, Emergency Treatment, Europe, Female, Humans, Hydrocortisone, Male, Prednisolone, Pregnancy, Pregnancy Complications, Steroid 21-Hydroxylase, Autoimmunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
